Aimei Health Technology Co., Ltd
AFJKAimei Health Technology Co., Ltd is a blank check company, also known as a special purpose acquisition company (SPAC), formed for the purpose of entering into a merger, share exchange, or similar business combination.
Earnings
Next report
Date not yet announcedCompetitors
By market cap
Profile
Aimei Health Technology Co., Ltd is a blank check company, also known as a special purpose acquisition company (SPAC), formed for the purpose of entering into a merger, share exchange, or similar business combination. The company primarily targets small-cap businesses within the biopharmaceutical, medical technology, and diagnostic services sectors across North America, Europe, and the Asia Pacific regions. Its core value proposition is providing emerging healthcare companies with an alternative path to public markets and access to U.S. capital.
Aimei Health is a specialized SPAC leveraging a management team with extensive experience in Asian markets and healthcare drug/device development to identify high-value innovation targets.
FAQ
- What is Aimei Health Technology Co., Ltd's market cap?
- Aimei Health Technology Co., Ltd (AFJK) has a market capitalization of $38.2M and trades on NASDAQ.
- Who are Aimei Health Technology Co., Ltd's competitors?
- Aimei Health Technology Co., Ltd's key competitors include Launch One Acquisition Corp. Class A Ordinary shares, American Exceptionalism Acquisition Corp. A, American Drive Acquisition Company Class A Ordinary Shares, and others. These companies compete in similar markets and product categories.
- Who does Aimei Health Technology Co., Ltd partner with?
- Aimei Health Technology Co., Ltd's notable partners include Spartan Capital Securities, LLC, Continental Stock Transfer & Trust Company, United Hydrogen Group Inc..
- Where is Aimei Health Technology Co., Ltd headquartered?
- Aimei Health Technology Co., Ltd is headquartered in United States of America. It has been publicly traded since 2024.